Vampire Bat Salivary Plasminogen Activator (Desmoteplase)
- 1 February 2003
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 34 (2), 537-543
- https://doi.org/10.1161/01.str.0000049764.49162.76
Abstract
Background and Purpose— Tissue-type plasminogen activator (tPA) promotes excitotoxic and ischemic injury within the brain. These findings have implications for the use of tPA in the treatment of acute ischemic stroke. The plasminogen activator from vampire bat ( Desmodus rotundus ) saliva ( D rotundus salivary plasminogen activator [DSPA]; desmoteplase) is an effective plasminogen activator but, in contrast to tPA, is nearly inactive in the absence of a fibrin cofactor. The purpose of this study was to compare the ability of DSPA and tPA to promote kainate- and N -methyl- d -aspartate (NMDA)–induced neurodegeneration in tPA−/− mice and wild-type mice, respectively. Methods— tPA−/− mice were infused intracerebrally with either tPA or DSPA. The degree of neuronal survival after hippocampal injection of kainate was assessed histochemically. Wild-type mice were used to assess the extent of neuronal damage after intrastriatal injection of NMDA in the presence of tPA or DSPA. Immunohistochemistry and fibrin zymography were used to evaluate DSPA and tPA antigen or activity. Results— Infusion of tPA into tPA−/− mice restored sensitivity to kainate-mediated neurotoxicity and activation of microglia. DSPA was incapable of conferring sensitivity to kainate treatment, even when infused at 10-fold higher molar concentration than tPA. The presence of tPA also increased the lesion volume induced by NMDA injection into the striatum of wild-type mice, whereas DSPA had no effect. Conclusions— DSPA does not promote kainate- or NMDA-mediated neurotoxicity in vivo. These results provide significant impetus to evaluate DSPA in patients with ischemic stroke.Keywords
This publication has 22 references indexed in Scilit:
- Tissue-Type Plasminogen Activator is Involved in the Process of Neuronal Death Induced by Oxygen–Glucose Deprivation in CultureJournal of Cerebral Blood Flow & Metabolism, 2001
- Effects of Tissue Type Plasminogen Activator in Embolic versus Mechanical Models of Focal Cerebral Ischemia in RatsJournal of Cerebral Blood Flow & Metabolism, 1999
- Nonproteolytic Neuroprotection by Human Recombinant Tissue Plasminogen ActivatorScience, 1999
- Neuronal cell death and tPANature, 1996
- Tissue Plasminogen Activator Induction in Purkinje Neurons After Cerebellar Motor LearningScience, 1995
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Structural Features Mediating Fibrin Selectivity of Vampire Bat Plasminogen ActivatorsPublished by Elsevier BV ,1995
- Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activatorNature, 1995
- Physiological consequences of loss of plasminogen activator gene function in miceNature, 1994
- The plasminogen activator family from the salivary gland of the vampire bat Desmodus rotundas: cloning and expressionGene, 1991